학술논문
143 Mesothelin (MSLN) targeting allogeneic CAR T cells engineered to overcome tumor immunosuppressive microenvironment
Document Type
article
Author
Source
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Subject
Language
English
ISSN
2051-1426